Top Markets
#1 DogBull DogBull +105.02%
#2 Siacoin Siacoin +53.17%
#3 ADO Protocol ADO Protocol +46.57%
#4 UnifAI Network UnifAI Network +44.82%
#5 MarsCoin MarsCoin +42.26%
#6 Useless Coin Useless Coin +23.51%
#7 Magma Finance Magma Finance +22.41%
#8 Ontology Gas Ontology Gas +20.59%
#9 Cash Cat Cash Cat +15.71%
#10 Apertum Apertum +14.51%
Coin of the day
DogBull DogBull
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Cuorips Inc. Cuorips Inc.

Cuorips Inc.

4894
Kedudukan dalam Saham #16184
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived... Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Harga Saham
$37.25
Modal Pasaran
$307.63M
Perubahan (1 hari)
-1.55%
Perubahan (1 tahun)
-26.02%
Negara
JP
Perdagangan Cuorips Inc. (4894)

Kategori

Healthcare
Pendapatan untuk Cuorips Inc. (4894)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Cuorips Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Cuorips Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH